Finally, our work was restricted to the identification of proteins altered by FBXW7 mutation; however, the results provided herein combined with recent literature implicating the function of PADI2 in other tumor types and of UCHL1 in serous ECs, as well as the potential to directly drug both proteins provides significant impetus for future research. This evidence concerns the gene PADI2 and neoplasm.